Skip to main content
Top

Current Cardiology Reports

Issue 6/2019

Content (12 Articles)

Is There a Need to Revise Goals in the Management of Dyslipidemias?

  • Dyslipidemia
  • Lipid Abnormalities and Cardiovascular Prevention (G De Backer, Section Editor)

David Sinning, Ulf Landmesser

Dyslipidemia Profiles in Patients with Peripheral Artery Disease

  • Dyslipidemia
  • Lipid Abnormalities and Cardiovascular Prevention (G De Backer, Section Editor)

Aaron W. Aday, Brendan M. Everett

Polygenic Hypercholesterolemia and Cardiovascular Disease Risk

  • Open Access
  • Coronary Heart Disease
  • Lipid Abnormalities and Cardiovascular Prevention (G De Backer, Section Editor)

Mahtab Sharifi, Marta Futema, Devaki Nair, Steve E. Humphries

Lifestyle Interventions to Prevent Cardiovascular Events After Stroke and Transient Ischemic Attack

Anantha R. Vellipuram, Gustavo Rodriguez, Prashanth Rawla, Alberto Maud, Salvador Cruz-Flores, Rakesh Khatri

Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes

  • Diabetes
  • Ischemic Heart Disease (D Mukherjee, Section Editor)

Thwe Htay, Kyaw Soe, Arianna Lopez-Perez, Amy HoangAnh Doan, Michael A. Romagosa, KoKo Aung

Refractory Angina: the Current State of Mechanical Therapies

  • Sympathectomy
  • Ischemic Heart Disease (D Mukherjee, Section Editor)

Amod Amritphale, Nupur Amritphale

Treatment Challenges in Patients with Acute Heart Failure and Severe Aortic Valve Stenosis

Tobias Schmidt, Christian Frerker

Transseptal Puncture: Devices, Techniques, and Considerations for Specific Interventions

Sharan Prakash Sharma, Rahul Nalamasu, Rakesh Gopinathannair, Chandrasekhar Vasamreddy, Dhanunjaya Lakkireddy

Device Closure of Patent Foramen Ovale for Cryptogenic Stroke: Patient Selection and Outcomes According to New Randomized Trials

  • Cerebral Ischemia
  • Structural Heart Disease (RJ Siegel and NC Wunderlich, Section Editors)

Adam M. Carroll, John D. Carroll

Ethics and Bias in Clinical Trial Enrollment in Stroke

Jennifer Juhl Majersik

Psychosocial Factors and Recovery After Acute Myocardial Infarction in Younger Women

Kim G. Smolderen, Anna Brush, Rachel P. Dreyer

Next-generation MRI contrast agents: preparing the field (Link opens in a new window)

New MRI contrast agents are reshaping diagnostic imaging, promising lower gadolinium exposure amid evolving practice guidelines. How can you optimise contrast selection, dosing, and patient care in this rapidly advancing field?

This content is intended for healthcare professionals outside of the UK.

Independent Medical Education Grant:
  • Bayer HealthCare Pharmaceuticals Inc.
Learn more Link opens in a new window
Image Credits
Abstract graphic of layered, concentric circular shapes in bright green, pink, blue, and purple on a dark blue background. The rings and segments form a complex radial pattern without text/© Springer Health+ IME